Sharing a good local news story for patients - early days for the adoption of gene therapies for IRD and to emphasis how new/cutting edge PYC ocular therapies are.
I get the feeling helping patients is what motivates Sue and the PYC team - and are striving hard towards.
The complexity/delivery of current tech is worth noting, PYC will surprise ease of an intravenous injection within a GP type consulting room vs full fledged operating theatre will surprise the industry I think
https://www.insightnews.com.au/sydney-surgeon-details-first-luxturna-gene-therapy-allowing-patient-to-see-stars/#mobile-site-navigation
- Forums
- ASX - By Stock
- PYC
- Interview with Sue Fletcher PYC CSO
Interview with Sue Fletcher PYC CSO, page-7
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $559.9M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 12.0¢ | $279.9K | 2.315M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 147929 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 834773 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 147929 | 0.120 |
13 | 978136 | 0.115 |
11 | 663187 | 0.110 |
13 | 1606450 | 0.105 |
15 | 1401739 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 834773 | 5 |
0.130 | 397621 | 3 |
0.135 | 750295 | 4 |
0.140 | 756230 | 8 |
0.145 | 443572 | 9 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |